Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-30 @ 9:59 AM
Study NCT ID:
NCT00359151
Status:
TERMINATED
Last Update Posted:
2021-03-03
First Post:
2006-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Celebrex Total Knee Arthroplasty Study
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-28
First Submit QC Date:
None
Study First Post Date:
2006-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-01
Last Update Post Date:
2021-03-03
Last Update Post Date Type:
ACTUAL